The company RNL Biostar has announced the opening of a new adult stem cell R&D facility in Germantown, Maryland.
Through iPS cell technology, scientists turn ordinary skin cells into retinal cells.
Dr. Francis Collins, the newly appointed director of NIH, states his intention for a practical, scientific focus at NIH.
While other countries are still trying to figure out what their federal regulatory laws should be, India is providing a fertile, friendly, and profitable market for new adult stem cell companies.
The University of California at Davis has been awarded two separate multi-million-dollar grants for the study of adult stem cells in the treatment of various neurodegenerative and blood diseases.
The adult stem cell company Stemedica has requested a meeting with the FDA as the first step in the clinical evaluation of its proprietary adult stem cell product for the treatment of ischemic stroke.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.